Medison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat in Canada and Israel

Medison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat in Canada and Israel

Medison Pharma Ltd a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today the expansion of its partnership with Albireo to a multi-regional agreement to commercialize Odevixibat in Canada and Israel, for the treatment of patients with cholestatic liver diseases. Albireo's vote of confidence in the commercial solution Medison offers allows us to continue demonstrating our ongoing commitment to accelerate access to highly innovative therapies in international markets", said Meir Jakobsohn, Founder and CEO of Medison and added "Expanding our partnership with Albireo to the Canadian market enables us to offer innovative solutions to patients suffering from rare cholestatic liver diseases and improve their lives also in this important market". "We are privileged to expand the access of Albireo's innovative treatment to additional markets and compliment Albireo's global commercial strategy", said Gil Gurfinkel, VP Corporate Development at Medison. "Our multi-regional platform makes us the partner-of-choice for emerging biotech companies seeking to make their innovative products available in international markets for the benefit of patients suffering from severe conditions". Odevixibat is approved in Europe as Bylvay

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!